ESC 365 - Impact of Colchicine on Cardiovascular Disease

Open Access

Impact of Colchicine on Cardiovascular Disease

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: European Society of Cardiology

Session type: Late-Breaking Science

Date: 29 August 2020

Time: 08:48 - 09:26

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

Online Session - Impact of Colchicine on Cardiovascular Disease - Host and discussant

Speaker: Professor M. Imazio (Udine, IT)

COLCOT Pharmacogenomics

Speaker: Professor M. Dube (Montreal, CA)

Impact of time-to-treatment initiation of colchicine on cardiovascular outcomes after myocardial infarction: insights from the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Speaker: Doctor N. Bouabdallaoui (Montreal, CA)

COPS Trial - Colchicine to Improve Cardiovascular Outcomes in ACS Patients

Speaker: Doctor J. Layland (Melbourne, AU)

4 speakers from this session

Professor Massimo Imazio

Hospital Santa Maria della Misericordia, Udine (Italy)

14 presentations

2 followers

Professor Marie-Pierre Dube

Montreal Heart Institute, Montreal (Canada)

1 presentation

0 follower

Doctor Nadia Bouabdallaoui

Montreal Heart Institute, Montreal (Canada)

1 presentation

0 follower

Doctor Jamie Layland

Peninsula Health, Melbourne (Australia)

1 presentation

0 follower

This platform is supported by